CIP
ATRC icon

Convergence Investment Partners’s AtriCure ATRC Stock Holding History

Convergence Investment Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,101
Closed -$271K – 304
2019
Q1 		$271K Sell
10,101
-5,858
-37% -$178K 0.06% 233
2018
Q4 		$488K Buy
+15,959
New +$497K 0.11% 189

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Convergence Investment Partners's ATRC Position: Q2 2019 in Review

Convergence Investment Partners sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 10,101 shares — an estimated $271K sold.

Convergence Investment Partners first reported a position in ATRC in Q4 2018 and held it in 2 quarters. The position peaked at $488K in Q4 2018. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

  • Convergence Investment Partners reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 10,101 AtriCure shares in Q2 2019, an estimated $271K.
  • Convergence Investment Partners first reported a position in AtriCure in Q4 2018 and held it in 2 quarters.
  • Convergence Investment Partners's AtriCure position peaked at $488K in Q4 2018.
  • 145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Convergence Investment Partners's 13F filing for Q2 2019, filed 23 Jul 2019.